Sphera Funds Management Ltd. Ascendis Pharma A/S Transaction History

Sphera Funds Management Ltd.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $2.07 Million - $3.12 Million	-26,529 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $2.71 Million - $3.6 Million	26,529 New	26,529 $3.11 Million
Q1 2021 May 17, 2021	SELL	$124.92 - $173.33 $2.95 Million - $4.09 Million	-23,599 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $1.36 Million - $1.64 Million	-9,000 Reduced 27.61%	23,599 $3.94 Million
Q3 2020 Nov 12, 2020	SELL	$134.29 - $154.32 $238,230 - $273,763	-1,774 Reduced 5.16%	32,599 $5.03 Million
Q2 2020 Aug 13, 2020	BUY	$110.87 - $156.01 $199,566 - $280,818	1,800 Added 5.53%	34,373 $5.08 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $4 Million - $5.98 Million	-41,200 Reduced 55.85%	32,573 $3.67 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $589,105 - $726,495	5,500 Added 8.06%	73,773 $0
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $621,500 - $1.3 Million	10,000 Added 17.16%	68,273 $8.04 Million
Q4 2018 Feb 14, 2019	SELL	$55.16 - $69.67 $1.9 Million - $2.4 Million	-34,400 Reduced 37.12%	58,273 $3.65 Million
Q3 2018 Nov 14, 2018	BUY	$63.77 - $76.28 $932,636 - $1.12 Million	14,625 Added 18.74%	92,673 $6.57 Million
Q2 2018 Aug 13, 2018	SELL	$58.55 - $73.92 $1.02 Million - $1.29 Million	-17,426 Reduced 18.25%	78,048 $5.19 Million
Q1 2018 May 10, 2018	SELL	$38.98 - $68.04 $1.33 Million - $2.31 Million	-34,000 Reduced 26.26%	95,474 $6.24 Million
Q3 2017 Nov 09, 2017	BUY	$26.89 - $37.1 $3.48 Million - $4.8 Million	129,474	129,474 $4.69 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.